ATE145556T1 - Verwendung von interleukin-4 zur behandlung der festen tumoren - Google Patents
Verwendung von interleukin-4 zur behandlung der festen tumorenInfo
- Publication number
- ATE145556T1 ATE145556T1 AT91918403T AT91918403T ATE145556T1 AT E145556 T1 ATE145556 T1 AT E145556T1 AT 91918403 T AT91918403 T AT 91918403T AT 91918403 T AT91918403 T AT 91918403T AT E145556 T1 ATE145556 T1 AT E145556T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- solid tumors
- interleukin
- date mar
- treat solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57896890A | 1990-09-06 | 1990-09-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE145556T1 true ATE145556T1 (de) | 1996-12-15 |
Family
ID=24315064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91918403T ATE145556T1 (de) | 1990-09-06 | 1991-09-03 | Verwendung von interleukin-4 zur behandlung der festen tumoren |
Country Status (12)
Country | Link |
---|---|
US (1) | US5382427A (de) |
EP (1) | EP0552243B1 (de) |
JP (1) | JPH06501017A (de) |
KR (1) | KR100229974B1 (de) |
AT (1) | ATE145556T1 (de) |
AU (1) | AU661979B2 (de) |
CA (1) | CA2091170A1 (de) |
DE (1) | DE69123361T2 (de) |
DK (1) | DK0552243T3 (de) |
GR (1) | GR3022321T3 (de) |
HU (1) | HU215389B (de) |
WO (1) | WO1992004044A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0490006B1 (de) * | 1990-12-13 | 1994-06-22 | Schering-Plough | Pharmazeutische Zusammensetzungen zur Behandlung von bösartigen B-Zellenkrankheiten |
US5679338A (en) * | 1994-05-12 | 1997-10-21 | Osteoarthritis Science, Inc. | Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues |
US6576236B1 (en) * | 1994-07-01 | 2003-06-10 | Dana Farber Cancer Institute | Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain |
US20020127201A1 (en) * | 1994-07-01 | 2002-09-12 | Dana-Farber Cancer Institute. | Methods for inhibiting T cell responses by manipulating a common cytokine receptor gamma-chain |
US5716612A (en) * | 1994-09-07 | 1998-02-10 | Schering Corporation | Use of IL-4 for potentiation of chemotherapeutic agents |
US7361332B2 (en) * | 1995-03-17 | 2008-04-22 | The Regents Of The University Of California | Treating tumors using implants comprising combinations of allogeneic cells |
WO1996029394A1 (en) * | 1995-03-17 | 1996-09-26 | The Regents Of The University Of California | Method for treating tumors |
US20080220025A1 (en) * | 1995-03-17 | 2008-09-11 | James Thompson | Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells |
US6277368B1 (en) | 1996-07-25 | 2001-08-21 | The Regents Of The University Of California | Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
RU2115429C1 (ru) * | 1997-07-22 | 1998-07-20 | Закрытое акционерное общество "Фосфосорб" | Рекомбинантный иммунотоксин на основе дифтерийного токсина и интерлейкина-2 (дт 482-il2) и способ его получения |
US6818213B1 (en) * | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
US6406693B1 (en) * | 1998-07-13 | 2002-06-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using antibodies to aminophospholipids |
ES2533255T3 (es) * | 1998-07-13 | 2015-04-08 | Board Of Regents, The University Of Texas System | Utilización de anticuerpos anti-aminofosfolípidos para el tratamiento del cáncer |
WO2000002587A1 (en) * | 1998-07-13 | 2000-01-20 | Board Of Regents, The University Of Texas System | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
US6923966B2 (en) | 1999-04-08 | 2005-08-02 | Schering Corporation | Melanoma therapy |
US6605273B2 (en) | 1999-04-08 | 2003-08-12 | Schering Corporation | Renal cell carcinoma treatment |
US6362162B1 (en) | 1999-04-08 | 2002-03-26 | Schering Corporation | CML Therapy |
US20040101825A1 (en) * | 2001-09-26 | 2004-05-27 | Van Meir Erwin G. | Viruses targeted to hypoxic cells and tissues |
US7285414B2 (en) * | 2000-09-26 | 2007-10-23 | Emory University | Viruses targeted to hypoxic cells and tissues |
CA2447360A1 (en) * | 2001-05-09 | 2002-11-14 | Alk-Abello A/S | Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
EP4285913A1 (de) * | 2022-05-30 | 2023-12-06 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Hochwirksame adoptive t-zelltherapie |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3882611T2 (de) * | 1987-08-03 | 1993-12-23 | Tasuku Honjo | Menschliches Interleukin-4, Expressionsvektoren dafür und diese enthaltende Transformanten. |
US4958007A (en) * | 1988-05-17 | 1990-09-18 | Schering-Plough Corp. | Extraction of human interleukin-4- from bacteria |
-
1991
- 1991-09-03 AT AT91918403T patent/ATE145556T1/de not_active IP Right Cessation
- 1991-09-03 DE DE69123361T patent/DE69123361T2/de not_active Expired - Fee Related
- 1991-09-03 HU HU9300624A patent/HU215389B/hu not_active IP Right Cessation
- 1991-09-03 WO PCT/US1991/006126 patent/WO1992004044A1/en active IP Right Grant
- 1991-09-03 JP JP3517814A patent/JPH06501017A/ja active Pending
- 1991-09-03 US US07/984,414 patent/US5382427A/en not_active Expired - Fee Related
- 1991-09-03 DK DK91918403.6T patent/DK0552243T3/da active
- 1991-09-03 EP EP91918403A patent/EP0552243B1/de not_active Expired - Lifetime
- 1991-09-03 AU AU88505/91A patent/AU661979B2/en not_active Ceased
- 1991-09-03 CA CA002091170A patent/CA2091170A1/en not_active Abandoned
- 1991-09-03 KR KR1019930700675A patent/KR100229974B1/ko not_active IP Right Cessation
-
1997
- 1997-01-21 GR GR970400085T patent/GR3022321T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0552243B1 (de) | 1996-11-27 |
AU661979B2 (en) | 1995-08-17 |
KR100229974B1 (ko) | 1999-11-15 |
WO1992004044A1 (en) | 1992-03-19 |
HUT63769A (en) | 1993-10-28 |
DE69123361T2 (de) | 1997-04-30 |
CA2091170A1 (en) | 1992-03-07 |
EP0552243A1 (de) | 1993-07-28 |
US5382427A (en) | 1995-01-17 |
HU9300624D0 (en) | 1993-05-28 |
AU8850591A (en) | 1992-03-30 |
DE69123361D1 (de) | 1997-01-09 |
DK0552243T3 (da) | 1997-03-10 |
GR3022321T3 (en) | 1997-04-30 |
HU215389B (hu) | 1998-12-28 |
JPH06501017A (ja) | 1994-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE145556T1 (de) | Verwendung von interleukin-4 zur behandlung der festen tumoren | |
ATE139447T1 (de) | Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen | |
DE69433889D1 (de) | Anwendung von 1,2,4-benzotriazinoxiden zur Herstellung eines Arzneimittels zur Behandlung von Tumoren | |
ATE232394T1 (de) | Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs | |
DE59407413D1 (de) | Verwendung von Leflunomid zur Hemmung von Interleukin 1 beta | |
ATE143260T1 (de) | Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen | |
DK471386D0 (da) | Farmaceutisk komposition til behandling af leukopeni | |
DE69130497D1 (de) | Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis | |
ATE161423T1 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
ATE220923T1 (de) | Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen | |
DE59407414D1 (de) | Verwendung von Leflunomid zur Hemmung von Tumornekrosefaktor alpha | |
ATE107168T1 (de) | Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression. | |
ATE174629T1 (de) | Herstellung von proteinen mittels protein 7b2 | |
DE69021257D1 (de) | Verwendung von IFN-gamma zur Herstellung einer pharmazeutischen Zusammensetzung für die Behandlung von ATL. | |
DE69924483D1 (de) | Kombinationstherapie zur behandlung von tumoren | |
ATE157010T1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
ATE289823T1 (de) | Erhöhung der migration oder proliferation von keratinocyten | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
ATE59780T1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
ATE225183T1 (de) | Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen | |
DE3881703D1 (de) | Behandlung zur verbesserung der eigenschaften von keratintextilmaterialien. | |
DE69131058D1 (de) | Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis | |
DE69117974D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen | |
DE59407412D1 (de) | Verwendung von Leflunomid zur Hemmung von Interleukin 1 alpha | |
DE3786442D1 (de) | Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |